Abstract
After injury the body normally undergoes a repair process, however when this event becomes deregulated the pathological condition of fibrosis occurs. There are many similarities with respect to the fundamental mechanisms that regulate sclerosis in different organ systems. In this review we utilize the pathological entity of glomerulosclerosis in the kidney to highlight some of the general paradigms whereby extracellular matrix (ECM) is deposited in greater quantities than it is degraded. Our review discusses how genetic and structural abnormalities of specific ECM components can result in fibrosis. In addition, we outline how some key growth factors, integrins and oxidative stress play a role in the development of glomerulosclerosis.
Current Pharmaceutical Design
Title: Regulation of Matrix Synthesis, Remodeling and Accumulation in Glomerulosclerosis
Volume: 15 Issue: 12
Author(s): Ambra Pozzi, Paul A. Voziyan, Billy G. Hudson and Roy Zent
Affiliation:
Abstract: After injury the body normally undergoes a repair process, however when this event becomes deregulated the pathological condition of fibrosis occurs. There are many similarities with respect to the fundamental mechanisms that regulate sclerosis in different organ systems. In this review we utilize the pathological entity of glomerulosclerosis in the kidney to highlight some of the general paradigms whereby extracellular matrix (ECM) is deposited in greater quantities than it is degraded. Our review discusses how genetic and structural abnormalities of specific ECM components can result in fibrosis. In addition, we outline how some key growth factors, integrins and oxidative stress play a role in the development of glomerulosclerosis.
Export Options
About this article
Cite this article as:
Pozzi Ambra, Voziyan A. Paul, Hudson G. Billy and Zent Roy, Regulation of Matrix Synthesis, Remodeling and Accumulation in Glomerulosclerosis, Current Pharmaceutical Design 2009; 15 (12) . https://dx.doi.org/10.2174/138161209787846748
DOI https://dx.doi.org/10.2174/138161209787846748 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Radiocontrast Nephropathy: Progress not Prevention
Current Cardiology Reviews Inflammatory Cytokines and Atherosclerosis Possible Application for the Gene Therapy
Vascular Disease Prevention (Discontinued) Vasoactive Renal Factors and the Progression of Diabetic Nephropathy
Current Pharmaceutical Design Hypoxia and Oxidative Stress in the Causation of Diabetic Retinopathy
Current Diabetes Reviews Prevention of Contrast Induced Nephropathy
Current Drug Therapy Antiviral Drugs that Target Cellular Proteins May Play Major Roles in Combating HIV Resistance
Current Pharmaceutical Design Compounds that Combine Aldose Reductase Inhibitory Activity and Ability to Prevent the Glycation (Glucation and/or Fructation) of Proteins as Putative Pharmacotherapeutic Agents
Drug Design Reviews - Online (Discontinued) Hyperglycemia to Nephropathy via Transforming Growth Factor Beta
Current Diabetes Reviews Micro RNA: An Epigenetic Regulator of Type 2 Diabetes
MicroRNA Point of NO Return for Nitrergic Nerves in Diabetes: A New Insight into Diabetic Complications
Current Pharmaceutical Design The First Approved Agent in the Glitazar’s Class: Saroglitazar
Current Drug Targets Nitric Oxide Synthase Inhibition and Renal Injury
Current Enzyme Inhibition Diabetes and Metallothionein
Mini-Reviews in Medicinal Chemistry Aldose Reductase in Diabetic Microvascular Complications
Current Drug Targets Low Baseline Urine Creatinine Excretion Rate Predicts Poor Outcomes among Critically Ill Acute Stroke Patients
Current Neurovascular Research Ectodomain Shedding of ACE and ACE2 as Regulators of Their Protein Functions
Current Enzyme Inhibition Human Leukocyte Antigens (HLA) Genes Association in Type 1 Diabetic Nephropathy
Endocrine, Metabolic & Immune Disorders - Drug Targets Molecular Genetic Approaches for Studying the Etiology of Diabetic Nephropathy
Current Molecular Medicine Long-term Exposure to Cadmium in Food and Cigarette Smoke, Liver Effects and Hepatocellular Carcinoma
Current Drug Metabolism Molecular Remodeling of the Insulin Receptor Pathway by Thiazolidinediones in Type 2 Diabetes Mellitus: A Brief Review
Protein & Peptide Letters